Literature DB >> 17914145

Maggot debridement therapy in chronic wound care.

Dominic C W Chan1, Daniel H F Fong, June Y Y Leung, N G Patil, Gilberto K K Leung.   

Abstract

OBJECTIVE: To review the current evidence on the mechanism of actions and clinical applications of maggot debridement therapy. DATA SOURCES: Literature search of PubMed and Medline was performed up to January 2007. STUDY SELECTION: Original and major review articles related to maggot debridement therapy were reviewed. Key words used in the literature search were 'maggot debridement therapy', 'wound healing', and 'chronic wound management'. DATA EXTRACTION: All relevant English and Chinese articles. DATA SYNTHESIS: The mechanism of such maggot therapy was shown to be due to the debridement, disinfection, and wound healing enhancement actions of maggot excretions/secretions. The efficacy of maggot debridement therapy in chronic wound management has been demonstrated in chronic venous ulcers, pressure ulcers, and diabetic ulcers. There is also a new delivery system for the excretions/secretions, which has been shown to be as effective as using live maggots.
CONCLUSIONS: Maggot debridement therapy has been shown to be a safe and effective means of chronic wound management. However, there are a number of limitations when considering its local applicability. Future development of the delivery system may help to overcome some of these limitations and improve its acceptability.

Entities:  

Mesh:

Year:  2007        PMID: 17914145

Source DB:  PubMed          Journal:  Hong Kong Med J        ISSN: 1024-2708            Impact factor:   2.227


  17 in total

1.  Maggot debridement therapy in the treatment of complex diabetic wounds.

Authors:  Michelle L Marineau; Mark T Herrington; Karen M Swenor; Lawrence J Eron
Journal:  Hawaii Med J       Date:  2011-06

2.  [Cutaneous wound healing. Therapeutic interventions].

Authors:  J Heinlin; S Schreml; P Babilas; M Landthaler; S Karrer
Journal:  Hautarzt       Date:  2010-07       Impact factor: 0.751

3.  The cost of wound debridement: a Canadian perspective.

Authors:  Kevin Y Woo; David Keast; Nancy Parsons; R Gary Sibbald; Nicole Mittmann
Journal:  Int Wound J       Date:  2013-07-09       Impact factor: 3.315

4.  Maggot excretions/secretions induces human microvascular endothelial cell migration through AKT1.

Authors:  Shou-yu Wang; Kai Wang; Yi Xin; De-cheng Lv
Journal:  Mol Biol Rep       Date:  2009-09-16       Impact factor: 2.316

5.  Maggots reveal a case of antemortal insect infestation.

Authors:  Kristina Baumjohann; Karl-Heinz Schiwy-Bochat; Markus Alexander Rothschild
Journal:  Int J Legal Med       Date:  2011-05-02       Impact factor: 2.686

6.  Evaluation of conventional therapeutic methods versus maggot therapy in the evolution of healing of tegumental injuries in Wistar rats with and without diabetes mellitus.

Authors:  Franciéle Souza Masiero; Patricia Jacqueline Thyssen
Journal:  Parasitol Res       Date:  2016-03-15       Impact factor: 2.289

7.  Maggot extracts promote regulatory T cell differentiation by upregulating Foxp3 in allergic rhinitis.

Authors:  Li Liu; Yu-Qin Deng; Wo-Er Jiao; Yue-Long Qiao; Ze-Zhang Tao; Yong Wang; Qing-Quan Hua; Shi-Ming Chen
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

Review 8.  A systematic review of therapeutic interventions for pressure ulcers after spinal cord injury.

Authors:  Mary Ann Regan; Robert W Teasell; Dalton L Wolfe; David Keast; William B Mortenson; Jo-Anne L Aubut
Journal:  Arch Phys Med Rehabil       Date:  2009-02       Impact factor: 3.966

9.  Selective debridement of burn wounds using hydrosurgery system.

Authors:  Mingzhou Yuan; Meifang Yin; Lijun Zhang; Jinghao Feng; Junyou Zhu; Ziheng Zhou; Bin Shu; Fei Zhou; Fangyingnan Zhang; Hanxiao Yin; Xiaoyan Wang; Shaohai Qi; Jun Wu
Journal:  Int Wound J       Date:  2019-11-29       Impact factor: 3.315

10.  Adjunct methods of the standard diabetic foot ulceration therapy.

Authors:  Dariusz Waniczek; Andrzej Kozowicz; Małgorzata Muc-Wierzgoń; Teresa Kokot; Elżbieta Swiętochowska; Ewa Nowakowska-Zajdel
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-13       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.